Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects.
D000328:Adult; D000367:Age Factors; D000368:Aged; D000783:Aneurysm; D001281:Atrial Fibrillation; D001786:Blood Glucose; D001794:Blood Pressure; D002561:Cerebrovascular Disorders; D002986:Clinical Trials as Topic; D003327:Coronary Disease; D005921:Glomerulonephritis; D006333:Heart Failure; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects / Q000627:therapeutic use; D006852:Hydrochlorothiazide / Q000009:adverse effects / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy* / Q000453:epidemiology*; D007008:Hypokalemia / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009017:Morbidity; D012110:Reserpine / Q000009:adverse effects / Q000627:therapeutic use; D012494:Sampling Studies; D014527:Uric Acid / Q000097:blood
D001786:Blood Glucose; D006852:Hydrochlorothiazide; D014527:Uric Acid; D006830:Hydralazine; D012110:Reserpine